Tumour growth and response to radiation

Basic Clinical Radiobiology, Fourth Edition

Volumn , Issue , 2009, Pages 78-101

  Zips, Daniel ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136369842     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15450-10     Document Type: Chapter

References (71)

1. Baumann M, Dubois W, Suit HD (1990). Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiat Res 123:325-30.
2. Baumann M, Liertz C, Baisch H, Wiegel T, Lorenzen J, Arps H (1994). Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother Oncol 32: 137-43.
3. Baumann M, Krause M, Zips D et al. (2003). Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse. Int J Radiat Biol 79: 547-59.
4. Beck-Bornholdt HP, Wurschmidt F, Vogler H (1987). Net growth delay: a novel parameter derived from tumor growth curves. Int J Radiat Oncol Biol Phys 13:773-7.
5. Begg AC, McNally NJ, Shrieve DC, Karcher H (1985). A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-6.
6. Begg AC, Haustermans K, Hart AA et al. (1999). The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 50: 13-23.
7. Bentzen SM, Thames HD (1996). Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 36: 247-51.
8. Bentzen SM, Atasoy BM, Daley FM et al. (2005). Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23: 5560-7.
9. Brown DC, Gatter KC (2002). Ki67 protein: the immaculate deception? Histopathology 40: 2-11.
10. Dorr W (1997). Three As of repopulation during fractionated irradiation of squamous epithelia:Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions. Int J Radiat Biol 72: 635-43.
11. Dubben HH, Thames HD, Beck-Bornholdt HP (1998). Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 47:167-74.
12. Elkind MM, Sutton H (1960). Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiat Res 13: 556-93.
13. Eriksen JG, Steiniche T, Overgaard J (2005). The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother Oncol 74: 93-100.
14. Fowler JF (1991). Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother Oncol 22: 156-8.
15. Fowler JE, Pandey P, Braswell NT, Seaver L (1994). Prostate specific antigen progression rates after radical prostatectomy or radiation therapy for localized prostate cancer. Surgery 116: 302-5.
16. Gerweck LE, Zaidi ST, Zietman A (1994). Multivariate determinants of radiocurability. I. Prediction of single fraction tumor control doses. Int J Radiat Oncol Biol Phys 29: 57-66.
17. Haitel A, Wiener HG, Migschitz B, Marberger M, Susani M (1997). Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas? Am J Clin Pathol 107: 229-35.
18. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100: 57-70.
19. Hansen O, Overgaard J, Hansen HS et al. (1997). Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother Oncol 43: 47-51.
20. Haustermans KM, Hofland I, van Poppel H et al. (1997). Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys 37: 1067-70.
21. Hessel F, Petersen C, Zips D et al. (2003). Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice. Int J Radiat Biol 79: 479-86.
22. Hessel F, Krause M, Helm A et al. (2004). Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation. Int J Radiat Biol 80:719-27.
23. Hill RP (1987). Excision assays. In: Kallman RF (eds) Rodent tumor models in experimental cancer therapy. New York: Pergamon Press, 67-75.
24. Hill RP, Milas L (1989). The proportion of stem cells in murine tumors. Int J Radiat Oncol Biol Phys 16:513-8.
25. Hommura F, Dosaka-Akita H, Mishina T et al. (2000). Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 6: 4073-81.
26. Hoskin PJ, Sibtain A, Daley FM, Saunders MI, Wilson GD (2004). The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol 72: 159-68.
27. Jensen V, Sorensen FB, Bentzen SM et al. (1998). Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Histopathology 32:536-46.
28. Jung H, Kruger HJ, Brammer I, Zywietz F, Beck-Bornholdt HP (1990). Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays. Int J Radiat Biol 57: 567-89.
29. Krause M, Hessel F, Zips D, Hilberg F, Baumann M (2004). Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma. Radiother Oncol 72: 95-101.
30. Krause M, Ostermann G, Petersen C et al. (2005). Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation. Radiother Oncol 76: 162-7.
31. Krause M, Zips D, Thames HD, Kummermehr J, Baumann M (2006). Preclinical evaluation of moleculartargeted anticancer agents for radiotherapy. Radiother Oncol 80: 112-22.
32. Kummermehr J, Dorr W, Trott KR (1992). Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated radiotherapy. BJR Suppl 24: 193-9.
33. Lanza G Jr, Cavazzini L, Borghi L, Ferretti S, Buccoliero F, Rubbini M (1990). Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables. Pathol Res Pract 186:608-18.
34. Lee WR, Hanks GE, Corn BW, Schultheiss TE (1995). Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy. Int J Radiat Oncol Biol Phys 31: 21-4.
35. Linder S, Parrado C, Falkmer UG, Blasjo M, Sundelin P, von Rosen A (1997). Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer 76:54-9.
36. Malaise EP, Chavaudra N, Tubiana M (1973). The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer 9: 305-12.
37. Miescher G (1929). Röntgentherapie der Hautkarzinome. Schweiz Med Wochenschr II:1225.
38. Munro TR, Gilbert CW (1961). The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br J Radiol 34: 246-51.
39. Overgaard J, Matsui M, Lindegaard JC et al. (1987). Relationship between tumor growth delay and modification of tumor-control probability of various treatments given as an adjuvant to irradiation. In:Kallman RF (ed.) Rodent tumor models in experimental cancer therapy. New York: Pergamon Press, 128-32.
40. Petersen C, Zips D, Krause M et al. (2001). Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys 51:483-93.
41. Petersen C, Eicheler W, Frommel A et al. (2003). Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice. Int J Radiat Biol 79: 469-77.
42. Potten CS, Wichmann HE, Dobek K et al. (1985). Cell kinetic studies in the epidermis of mouse. III. The percent labelled mitosis (PLM) technique. Cell Tissue Kinet 18: 59-70.
43. Rautiainen E, Haapasalo H, Sallinen P, Rantala I, Helen P, Helin H (1998). Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded material. Histopathology 32: 43-50.
44. Rew DA, Wilson GD (2000). Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Eur J Surg Oncol 26: 405-17.
45. Rofstad EK (1989). Local tumor control following single dose irradiation of human melanoma xenografts:relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse. Cancer Res 49: 3163-7.
46. Rofstad EK, Wahl A, Brustad T (1986). Radiation response of human melanoma multicellular spheroids measured as single cell survival, growth delay, and spheroid cure: comparisons with the parent tumor xenograft. Int J Radiat Oncol Biol Phys 12: 975-82.
47. Roland NJ, Caslin AW, Bowie GL, Jones AS (1994). Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol Allied Sci 19: 13-8.
48. Roser F, Samii M, Ostertag H, Bellinzona M (2004). The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37-44.
49. Sarbia M, Bittinger F, Porschen R et al. (1996). The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. Br J Cancer 74: 1012-6.
50. Schmid HP, McNeal JE, Stamey TA (1993). Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031-40.
51. Schmidt-Ullrich RK, Contessa JN, Dent P et al. (1999). Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig 7:321-30.
52. Sinclair WK, Morton RA (1965). X-Ray and ultraviolet sensitivity of synchronized Chinese hamster cells at various stages of the cell cycle. Biophys J 5: 1-25.
53. Spratt JS, Meyer JS, Spratt JA (1996). Rates of growth of human neoplasms: Part II. J Surg Oncol 61:68-83.
54. Steel GG (1977). The growth kinetics of tumours. Oxford:Oxford University Press.
55. Steel GG, McMillan TJ, Peacock JH (1989). The 5Rs of radiobiology. Int J Radiat Biol 56: 1045-8.
56. Suit HD, Sedlacek R, Thames HD (1987). Radiation dose-response assays of tumor control. In: Kallman RF (ed.) Rodent tumor models in experimental cancer therapy. New York: Pergamon Press, 138-48.
57. Taftachi R, Ayhan A, Ekici S, Ergen A, Ozen H (2005). Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. BJU Int 95: 650-4.
58. Terry NH, White RA, Meistrich ML, Calkins DP (1991). Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry 12: 234-41.
59. Thames HD, Ruifrok AC, Milas L et al. (1996). Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma:downregulation of apoptosis as a possible mechanism. Int J Radiat Oncol Biol Phys 35:951-62.
60. Thor AD, Liu S, Moore DH, 2nd, Edgerton SM (1999). Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17: 470-7.
61. Trott KR, Kummermehr J (1991). Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 22: 159-60.
62. Trott KR, Maciejewski B, Preuss-Bayer G, Skolyszewski J (1984). Dose-response curve and split-dose recovery in human skin cancer. Radiother Oncol 2: 123-9.
63. Urano M, Kahn J (1987). Some practical questions in the tumor regrowth assay. In: Kallman RF (ed.) Rodent tumor models in experimental cancer therapy. New York: Pergamon Press, 122-7.
64. Walker AM, Suit HD (1983). Assessment of local tumor control using censored tumor response data. Int J Radiat Oncol Biol Phys 9: 383-6.
65. Wheldon TE, Abdelaal AS, Nias AH (1977). Tumour curability, cellular radiosensitivity and clonogenic cell number. Br J Radiol 50: 843-4.
66. Withers HR. The four Rs of radiotherapy. In: Lett JT, Adler H (eds) Advances in radiation biology, New York: Academic Press, 1975.
67. Yaromina A, Zips D, Thames HD et al. (2006). Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) cell lines in nude mice: The need for a multivariate approach in biomarker studies. Radiother Oncol 81: 122-9.
68. Zips D, Eicheler W, Bruchner K et al. (2001). Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol 77: 1185-93.
69. Zips D, Hessel F, Krause M et al. (2005). Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice. Int J Radiat Oncol Biol Phys 61:908-14.
70. Kallman RF (1987). Rodent tumor models in experimental cancer therapy. New York: Pergamon Press.
71. Steel GG (1977). The growth kinetics of tumours. Oxford:Oxford University Press.